Pyxis Oncology, Inc. (PYXS) (CIK 0001782223) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001437749-25-037150
- Form
- CORRESP
- Filer
- Pyxis Oncology, Inc. (PYXS) (CIK 0001782223)
- CIK
- 0001782223
- Ticker
- PYXS
- Filed
- 2025-12-08
- SIC industry
- 2834
- HQ
- Boston, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1782223/000143774925037150/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗